Homepage

United in Pride

This Pride Month, we can all do something

Join Us

TREAT Asia Launches Community-led Monitoring Dashboard

amfAR and its partners aim to help improve HIV and hepatitis service delivery in India and Indonesia.

Read More

Curing HIV: The Road Ahead

Read the latest updates on eradicating the virus.

Read More

amfAR Awards New Mathilde Krim Fellowship

Researcher Dr. Steven de Taeye will explore how antibodies might be exploited to develop a cure for HIV.

Read More

amfAR Cure Trial
Shows Proof of Concept

Combination immunotherapy study
sheds light on curing HIV.

Read More

amfAR, The Foundation for AIDS Research, is dedicated to ending the global AIDS epidemic through innovative research.

Researchers Can Now Better Predict COVID-19 Severity

New discovery may help those living with SARS-CoV-2 who often fare the worst, including people with untreated HIV.

Learning from Mpox

In a new policy brief, amfAR and the O’Neill Institute discuss what mpox taught us about responding to public health threats.

Better Data, Better Health

Smita Nimkar, a researcher in amfAR’s TREAT Asia network, explains how improving her data skills as a Fogarty-IeDEA trainee is enriching her research on children living with HIV.

amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and advocacy. Since 1985, amfAR has invested nearly $617 million in its programs and has awarded more than 3,500 grants to research teams worldwide.

November 2022 Issue

Innovations

How Many Have Been Cured? A summary of HIV cure, or treatment-free control cases to date.

Published biannually, Innovations provides updates on amfAR’s research, prevention, education, and policy initiatives; reports from amfAR-sponsored conferences and symposia; overviews of major HIV/AIDS-related issues; and highlights from recent fundraising events.

Read the latest issue.

Research Grants

amfAR utilizes formal requests for proposals to solicit grant applications for both targeted and general HIV/AIDS research. Proposals are then peer reviewed by the Scientific Advisory Committee on the basis of their relevance, scientific merit, and promise. To date, amfAR has awarded more than 3,500 grants to research teams worldwide.

Target Grants

Submission Deadline:
1:00 PM, June 29, 2023

Read more

General Grant Information

Learn how to apply and see what we’ve recently supported

Read more

Donate to amfAR: Fuel Lifesaving Research

Make your contribution today and join the fight to #CureAIDS. Your support contributes to the advancement of amfAR’s cutting-edge HIV/AIDS research.

Show the world that a cure isn’t just possible—it’s within reach.